IBDEI1SA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29864,1,4,0)
 ;;=4^I50.33
 ;;^UTILITY(U,$J,358.3,29864,2)
 ;;=^5007246
 ;;^UTILITY(U,$J,358.3,29865,0)
 ;;=I50.40^^135^1370^9
 ;;^UTILITY(U,$J,358.3,29865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29865,1,3,0)
 ;;=3^Systolic & Diastolic Congestive Heart Failure,Combined Unspec
 ;;^UTILITY(U,$J,358.3,29865,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,29865,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,29866,0)
 ;;=I51.7^^135^1370^2
 ;;^UTILITY(U,$J,358.3,29866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29866,1,3,0)
 ;;=3^Cardiomegaly
 ;;^UTILITY(U,$J,358.3,29866,1,4,0)
 ;;=4^I51.7
 ;;^UTILITY(U,$J,358.3,29866,2)
 ;;=^5007257
 ;;^UTILITY(U,$J,358.3,29867,0)
 ;;=I42.6^^135^1370^1
 ;;^UTILITY(U,$J,358.3,29867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29867,1,3,0)
 ;;=3^Alcoholic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,29867,1,4,0)
 ;;=4^I42.6
 ;;^UTILITY(U,$J,358.3,29867,2)
 ;;=^5007197
 ;;^UTILITY(U,$J,358.3,29868,0)
 ;;=I50.1^^135^1370^8
 ;;^UTILITY(U,$J,358.3,29868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29868,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,29868,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,29868,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,29869,0)
 ;;=I50.20^^135^1370^13
 ;;^UTILITY(U,$J,358.3,29869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29869,1,3,0)
 ;;=3^Systolic Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,29869,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,29869,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,29870,0)
 ;;=I50.21^^135^1370^10
 ;;^UTILITY(U,$J,358.3,29870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29870,1,3,0)
 ;;=3^Systolic Heart Failure,Acute
 ;;^UTILITY(U,$J,358.3,29870,1,4,0)
 ;;=4^I50.21
 ;;^UTILITY(U,$J,358.3,29870,2)
 ;;=^5007240
 ;;^UTILITY(U,$J,358.3,29871,0)
 ;;=I50.22^^135^1370^12
 ;;^UTILITY(U,$J,358.3,29871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29871,1,3,0)
 ;;=3^Systolic Heart Failure,Chronic
 ;;^UTILITY(U,$J,358.3,29871,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,29871,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,29872,0)
 ;;=I50.23^^135^1370^11
 ;;^UTILITY(U,$J,358.3,29872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29872,1,3,0)
 ;;=3^Systolic Heart Failure,Acute on Chronic
 ;;^UTILITY(U,$J,358.3,29872,1,4,0)
 ;;=4^I50.23
 ;;^UTILITY(U,$J,358.3,29872,2)
 ;;=^5007242
 ;;^UTILITY(U,$J,358.3,29873,0)
 ;;=I50.30^^135^1370^6
 ;;^UTILITY(U,$J,358.3,29873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29873,1,3,0)
 ;;=3^Diastolic Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,29873,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,29873,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,29874,0)
 ;;=I50.9^^135^1370^7
 ;;^UTILITY(U,$J,358.3,29874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29874,1,3,0)
 ;;=3^Heart Failure,Unspec (CHF Unspec)
 ;;^UTILITY(U,$J,358.3,29874,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,29874,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,29875,0)
 ;;=I50.31^^135^1370^3
 ;;^UTILITY(U,$J,358.3,29875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29875,1,3,0)
 ;;=3^Diastolic Heart Failure,Acute
 ;;^UTILITY(U,$J,358.3,29875,1,4,0)
 ;;=4^I50.31
 ;;^UTILITY(U,$J,358.3,29875,2)
 ;;=^5007244
 ;;^UTILITY(U,$J,358.3,29876,0)
 ;;=I30.0^^135^1371^5
 ;;^UTILITY(U,$J,358.3,29876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29876,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,29876,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,29876,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,29877,0)
 ;;=I34.8^^135^1371^6
 ;;^UTILITY(U,$J,358.3,29877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29877,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
